Market Authorization of Biological Products in India
Definition of
Biological Products:
According to DBT, Biologic drugs or biologics (also called as biopharmaceuticals or recombinant therapeutics) refer broadly to substances produced by living cells used in the treatment, diagnosis or prevention of diseases [1].
List of Biological
Products:
1. |
Sera |
2. |
Solution of serum proteins intended for injection |
3. |
Vaccines for parenteral injections |
5. |
Antigen |
6. |
Antitoxins |
7. |
Neo-arsphenamine and analogous substances used for the specific treatment of infective diseases |
8. |
Insulin |
9. |
Pituitary (Posterior Lobe) Extract |
10. |
Adrenaline and Solutions of Salts of Adrenaline |
11. |
Antibiotics and preparations thereof in a form to be administered parenterally |
12. |
Any
other preparation which is meant for parenteral administration as such or
after being made up with a solvent or medium or any other sterile product
and which- (a) requires to be stored in a refrigerator; or (b) does not
require to be stored in a refrigerator; |
13. |
Ophthalmic preparations |
14. |
Bacteriophages |
Regulatory Pathway
for Biological Product:
References:
[1] Draft guideline for preclinical evaluation of similar biologics in India by DBT, 2011
a. Submission of Clinical Trial Application for Evaluating Safety and Efficacy
b. Requirements for permission of New Drug Approval
c. Post approval changes in Biological Products: Quality Safety and Efficacy Documents
d. Preparation of the Quality Information for Drug Submission for New Drug Approval: Biotechnological/Biological Products
[3] Schedule Y
[4] Checklist for Filing Form 44 for Permission to conduct Clinical Trial
[5] Checklist for Filing Form 29 for Manufacturing Test Batches
[6] Checklist for Filing Biological NDA
[7] Pharmacovigilance Programme of India
[8] Guidelines on Similar Biologics
[9] Guidelines on Good Distribution Practices for Biological Products